Crispr Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $55M | 876k | 62.60 |
| 2023-09-30 | $40M | 873k | 45.39 |
| 2023-06-30 | $52M | 922k | 56.14 |
| 2023-03-31 | $38M | 847k | 45.23 |
| 2022-12-31 | $35M | 853k | 40.65 |
| 2022-09-30 | $55M | 841k | 65.33 |
| 2022-06-30 | $56M | 924k | 60.75 |
| 2022-03-31 | $64M | 1.0M | 62.77 |
| 2021-12-31 | $87M | 1.1M | 75.84 |
| 2021-09-30 | $113M | 1.0M | 111.93 |
| 2021-06-30 | $172M | 1.1M | 161.89 |
| 2021-03-31 | $128M | 1.1M | 121.85 |
| 2020-12-31 | $126M | 823k | 153.11 |
| 2020-09-30 | $59M | 713k | 82.05 |
| 2020-06-30 | $73M | 726k | 100.00 |
| 2020-03-31 | $36M | 852k | 42.02 |
| 2019-12-31 | $44M | 721k | 60.87 |
| 2019-09-30 | $31M | 730k | 42.55 |
| 2019-06-30 | $38M | 799k | 47.09 |
| 2019-03-31 | $31M | 891k | 34.78 |
| 2018-12-31 | $22M | 775k | 28.60 |
| 2018-09-30 | $26M | 596k | 44.32 |
| 2018-06-30 | $22M | 382k | 58.70 |
| 2018-03-31 | $20M | 447k | 45.72 |
| 2017-12-31 | $10M | 443k | 23.48 |
| 2017-09-30 | $1.7M | 80k | 20.83 |
| 2017-06-30 | $1.3M | 80k | 16.02 |
| 2017-03-31 | $1.7M | 80k | 21.78 |